Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Hairless HRS/J mice resist Bacillus anthracis skin infections due to high numbers of immune cells, not because they lack hair follicles.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Mice with damaged skin or hair follicles are more susceptible to anthrax infection.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Ichthyoses are genetic skin disorders that affect the skin's barrier function.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Better hair loss models needed for research.

New genetic discoveries in alopecia areata could lead to better treatments.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

A new genetic mutation in the CDH3 gene causes hair loss and eye problems in young people.

SFRP2 and PTGDS may be key factors in female hair loss.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Hair loss, known as androgenetic alopecia, is mainly caused by genetics, but also by hormone imbalances, shrinking hair follicles, inflammation, and environmental factors.

Female pattern hair loss affects 32.3% of women, increasing with age and showing no racial differences.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Neuroactive steroids and the enzyme 5α-reductase might be involved in the development of Tourette's syndrome.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.